Search

Author/Creator Akard, Luke P.

2. Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib. (January 2017)

Authors:
Ailawadhi, Sikander; Akard, Luke P.; Miller, Carole B.; Jillella, Anand; DeAngelo, Daniel J.; Ericson, Solveig G.; Lin, Felice; Warsi, Ghulam; Radich, Jerald
Journal:
Therapeutic advances in hematology
Issue:
Volume 8:Number 1(2017)
Page Start:
3
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia. Issue 29 (10th October 2021)

Authors:
Desai, Pinkal M.; Brown, Janice; Gill, Saar; Solh, Melham M.; Akard, Luke P.; Hsu, Jack W.; Ustun, Celalettin; Andreadis, Charalambos; Frankfurt, Olga; Foran, James M.; Lister, John; Schiller, Gary J.; Wieduwilt, Matthew J.; Pagel, John M.; Stiff, Patrick J.; Liu, Delong; Khan, Irum; Stock, Wendy...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 29(2021)
Page Start:
3261
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗